Published in Medical Letter on the CDC and FDA, January 29th, 2006
A federal jury in early September found that Stratagene infringed two key Third Wave patents covering its proprietary molecular methods. The jury also has found Stratagene liable for willful patent infringement and awarded Third Wave $5.3 million in damages. Third Wave had sought the additional damages, given the willful infringement verdict.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.